Diagnosis of Neonatal Congenital Heart Disease: : A Combination of Heart Murmur, SpO2 Abnormality, Tachypnea, and Extracardiac Malformations
Authors: 
Kai Chen, Jiao Wang, Huihui Zhou, Xiang Huang Academic Editor: Songwen TanAuthors Info & Claims
Abstract
Congenital heart disease (CHD) is one of the commonest congenital malformations that are mostly asymptomatic at birth, which challenges the diagnosis of neonatal CHD. An early accurate prenatal diagnosis will give parents a choice, as well as the opportunity to plan the delivery and improve the postnatal outcome. The purpose of the study is to evaluate the value of heart murmurs, SpO2 abnormalities, tachypnea, and extracardiac malformations in screening neonatal CHD. All 4500 newborns in the obstetrics department of our hospital from January 2019 to January 2020 are selected as study subjects. Newborns were grouped according with the presence of heart murmurs, tachypnea, transdermal SpO2<95%, and extracardiac malformations alone or in combination (≥3). Patients with murmur, tachypnea, and abnormal SpO2 were assigned into group A, those with murmur, tachypnea, and extracardiac malformations into group B, those with murmurs, SpO2, and extracardiac malformations into group C, those with SpO2, tachypnea, and extracardiac malformations into group D, and those with all four into group E. The color echocardiography identified 65 children with CHD (1.4%) among the included 4,500 newborns. When murmur, tachypnea, abnormal SpO2, and extracardiac malformation were independently used to diagnose CHD, the sensitivity ranged from 30.68% to 51.26%, with specificity ranging from 47.36% to 82.65% and Youden’s index (YI) ranging from 0.13 to 0.36. When murmur, tachypnea, abnormal SpO2, extracardiac malformation were together used to diagnose CHD, 91.23% sensitivity, 95.26 specificity, and 0.91 YI were observed. In conclusion, a combination of four indicators, murmur, tachypnea, abnormal SpO2, and extracardiac malformation yielded good performance in diagnosing neonatal CHD.
References
[1]
R. Sun, M. Liu, L. Lu, Y. Zheng, and P. Zhang, “Congenital heart disease: causes, diagnosis, symptoms, and treatments,” Cell Biochemistry and Biophysics, vol. 72, no. 3, pp. 857–860, 2015.
[2]
L. Zhao, L. Chen, T. Yang, T. Wang, S. Zhang, L. Chen, Z. Ye, L. Luo, and J. Qin, “Birth prevalence of congenital heart disease in China, 1980-2019: a systematic review and meta-analysis of 617 studies,” European Journal of Epidemiology, vol. 35, no. 7, pp. 631–642, 2020.
[3]
S. Han, C. Y. Wei, Z. L. Hou, Y. X. Li, Y. C. Ding, X. F. Guang, D. Huang, Z. H. Na, W. M. Chen, and G. L. Jian, “Prevalence of congenital heart disease amongst schoolchildren in Southwest China,” Indian Pediatrics, vol. 57, no. 2, pp. 138–141, 2020.
[4]
P. Judge and G. Meckler Mshs, “Congenital heart disease in pediatric patients: recognizing the undiagnosed and managing complications in the emergency department,” Pediatric Emergency Medicine Practice, vol. 13, no. 5, pp. 1–28, 2016.
[5]
E. Garne, M. S. Olsen, S. P. Johnsen, V. Hjortdal, H. O. Andersen, H. Nissen, L. Sondergaard, J. Videbaek, and D Danish Register of Congenital Heart, “How do we define congenital heart defects for scientific studies?” Congenital Heart Disease, vol. 7, no. 1, pp. 46–49, 2012.
[6]
X. J. Ma and G. Y. Huang, “Current status of screening, diagnosis, and treatment of neonatal congenital heart disease in China,” World Journal of Pediatrics, vol. 14, no. 4, pp. 313–314, 2018.
[7]
P. S. McQuillen, A. J. Barkovich, S. E. Hamrick, M. Perez, P. Ward, D. V. Glidden, A. Azakie, T. Karl, and S. P. Miller, “Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects,” Stroke, vol. 38, no. 2, pp. 736–741, 2007.
[8]
T. A. Glauser, L. B. Rorke, P. M. Weinberg, and R. R. Clancy, “Congenital brain anomalies associated with the hypoplastic left heart syndrome,” Pediatrics, vol. 85, no. 6, pp. 984–990, 1990.
[9]
W. Liu, J. Q. Cai, M. J. Tang, and Q. J. Yang, “Bioinformatics-Based Identification of lncRNA-miRNA-mRNA Network in Dilated Cardiomyopathy and Drug Prediction,” Journal of Nanomaterials, vol. 2021, 10 pages, 2021.
[10]
W. Liu, J. Ye, J. Q. Cai, M. F. Xie, M. J. Tang, and Q. J. Yang, “Immune-Related Genes: Potential Regulators and Drug Therapeutic Targets in Hypertrophic Cardiomyopathy,” Journal of Nanomaterials, vol. 2021, 14 pages, 2021.
[11]
C. H. Meller, S. Grinenco, H. Aiello, A. Cordoba, M. M. Saenz-Tejeira, P. Marantz, and L. Otano, “Congenital heart disease, prenatal diagnosis and management,” Archivos Argentinos de Pediatría, vol. 118, no. 2, pp. e149–e161, 2020.
[12]
E. M. Leusveld, R. M. Kauling, L. W. Geenen, and J. W. Roos-Hesselink, “Heart failure in congenital heart disease: management options and clinical challenges,” Expert Review of Cardiovascular Therapy, vol. 18, no. 8, pp. 503–516, 2020.
[13]
J. Bodegard, P. T. Skretteberg, K. Gjesdal, K. Pyorala, S. E. Kjeldsen, K. Liestol, G. Erikssen, and J. Erikssen, “Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men,” Journal of Internal Medicine, vol. 271, no. 6, pp. 581–588, 2012.
[14]
C. L. Hermansen and A. Mahajan, “Newborn respiratory distress,” American Family Physician, vol. 92, no. 11, pp. 994–1002, 2015.
[15]
N. Naqvi, V. L. Doughty, L. Starling, R. C. Franklin, S. Ward, P. E. F. Daubeney, and I. M. Balfour-Lynn, “Hypoxic challenge testing (fitness to fly) in children with complex congenital heart disease,” Heart, vol. 104, no. 16, pp. 1333–1338, 2018.
[16]
R. C. Rosa, R. F. Rosa, P. R. Zen, and G. A. Paskulin, “Congenital heart defects and extracardiac malformations,” Revista Paulista de Pediatria, vol. 31, no. 2, pp. 243–251, 2013.
[17]
J. Marek, V. Tomek, J. Skovranek, V. Povysilova, and M. Samanek, “Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience,” Heart, vol. 97, no. 2, pp. 124–130, 2011.
[18]
J. I. Hoffman, “Confirming the value of pulse oximetry screening for diagnosing critical congenital heart disease,” Evidence-Based Medicine, vol. 18, no. 3, p. e26, 2013.
[19]
E. Goldmuntz, “The epidemiology and genetics of congenital heart disease,” Clinics in Perinatology, vol. 28, no. 1, pp. 1–10, 2001.
[20]
A. K. Ewer, A. T. Furmston, L. J. Middleton, J. J. Deeks, J. P. Daniels, H. M. Pattison, R. Powell, T. E. Roberts, P. Barton, P. Auguste, A. Bhoyar, S. Thangaratinam, A. M. Tonks, P. Satodia, S. Deshpande, B. Kumararatne, S. Sivakumar, R. Mupanemunda, and K. S. Khan, “Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness,” Health Technology Assessment, vol. 16, no. 2, pp. 1–184, 2012.
Recommendations
Congenital Heart Disease: An Ontology-Based Approach for the Examination of the Cardiovascular System
KES '08: Proceedings of the 12th international conference on Knowledge-Based Intelligent Information and Engineering Systems, Part ICongenital Heart Disease (CHD) represents the most common group of congenital malformations of the heart and of its blood vessels. In this paper, we present an ontology-based approach to detect abnormalities and malformations due to CHD. In particular, ...
Rectal atresia, choanal atresia and congenital heart disease: a rare association
Rectal atresia is an extremely rare anorectal malformation. A unique case of rectal atresia presenting as an imperforate membrane associated with congenital cardiac malformations and unilateral choanal atresia in a newborn is reported. Ultrasound ...
Cardiovascular Modeling of Congenital Heart Disease Based on Neonatal Echocardiographic Images
This paper proposes a 3-D cardiovascular modeling system based on neonatal echocardiographic images. With the system, medical doctors can interactively construct patient-specific cardiovascular models, and share the complex topology and the shape ...
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
Copyright © 2021 Kai Chen et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publisher
Hindawi Limited
London, United Kingdom
Publication History
Published: 01 January 2021
Qualifiers
- Research-article
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 0Total Downloads
- Downloads (Last 12 months)0
- Downloads (Last 6 weeks)0
Reflects downloads up to 13 Feb 2025